| Document Date: 2014-06-24 19:14:13
Open Document File Size: 116,05 KBShare Result on Facebook
City Kidorf / Montoya / / Company Fleming / New England Journal / Kraft / Kovas AE / GE / Knudsen / Rothbard AB / Esagoff AE / / Facility Managed Care Pharmacy / Public Library of Science One / / IndustryTerm minimal psychosocial services / methadone services / psychosocial services / moderate services / Treatment of depression / intensive services / supplementary services / / MedicalCondition Given that depression / HIV / substance use disorders / hepatitis C / cocaine dependence / withdrawal syndrome / concurrent depression / Addictive Diseases / opiate dependence / depression / substance dependence / / MedicalTreatment psychological counseling / pharmacotherapies / psychotherapy / cognitive-behavioral therapy / cognitive-behavior therapy / counseling / pharmacotherapy / / Movie Quality of Life / / Organization American Psychiatric Association / Alcoholics Anonymous / Veterans Administration / / Person Stanton V / Schroeder JR / Ling W. Comparison / Jia W. Long-term / Andrew J. Saxon / Maria A. Sullivan / / Position therapist / King / counselor / Patients Receiving Buprenorphine/Naloxone Original Author / physician / Roman PM / psychosocial therapist / / Product Naloxone / Suboxone / Subutex / / PublishedMedium New England Journal of Medicine / American Journal of Psychiatry / Journal of Consulting and Clinical Psychology / / Region New England / / Technology http / pdf / / URL http /
SocialTag |
PCSS Guidance Topic: Psychosocial Aspects of Treatment in Patients Receiving Buprenorphine/Naloxone Original Author: Andrew J. Saxon, M.D. Last Updated: [removed]Maria A. Sullivan, M.D., Ph.D.) Guideline Coverage: Thi